Qualified Rehabilitation After Radical Treatment for Bladder Cancer

  • Michael ZellnerEmail author
  • David Ridderskamp
  • Mohamed Fawzy
Living reference work entry


Urological tumor diseases and consecutive invasive therapy with temporary or permanent impairments of health are a biographical break. During the early phase after radical intervention, a professional specific urological care should be carried out to deal with subjective as well as objective problems (e.g., incontinence, erectile dysfunction, stoma care, and metabolic disturbances). Usually, the hospitals that undertake the acute postoperative care would be underequipped and have personal and administrative limitations to carry out the postoperative rehabilitation. Nevertheless, urology outpatient clinics have much less resources to meet the necessary requirements for a qualified rehabilitation. Through an immediate post-interventional, specific urological rehabilitation, negative consequences of the disease and/or invasive therapy procedures can be markedly reduced and the viability or self-employment and reintegration into the social environment of the patient concerned possible. By the time, the urological rehabilitation has developed into a sophisticated, scientifically oriented subdiscipline within urology with further improvement of the rehabilitation potential. It is important to diagnose the somatic, mental, and social impairments. However, a prerequisite for a quality-oriented implementation is the exclusive support in adequately staffed and infrastructure-oriented treatment facilities under the supervision of qualified and experienced main occupational rehabilitation urologists (specific to the urological rehabilitation center). For the “overall outcome” of invasively treated urological tumor patients, this topic must be given a further and growing place in urological education. It is not permissible (again) to make the mistake of leaving this important urological subdiscipline to other specialist groups from unconsidered and/or lack of interest.


Stoma Care Medicated Urethral System For Erection (MUSE) Pelvic Floor Muscles Neobladder Urinary Diversion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Abdel-Fattah M, Rizk DE. Diabetes mellitus and female urinary incontinence: a time for change. Int Urogynecol J. 2012;23(4):1481–2.CrossRefPubMedGoogle Scholar
  2. Abdel-Latif M, Mosbah A, El Bahnasawy MS, Elsawy E, Shaaban AA. Asymptomatic bacteriuria in men with orthotopic ileal neobladders: possible relationship to nocturnal enuresis. BJU Int. 2005;96(3):391–6.CrossRefPubMedGoogle Scholar
  3. Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence – 2nd international consultation on incontinence. Plymouth, Plymbridge Distributors Ltd; 2002.Google Scholar
  4. Ahmadi H, Skinner EC, Simma-Chiang V, Miranda G, Cal J, Penson DF, Daneshmand S. Urinary functional outcome following radical cystoprostatectomy and ileal neobladder reconstruction in male patients. J Urol. 2013;189(5):1782–8.CrossRefPubMedGoogle Scholar
  5. Althof SE. Quality of life and erectile dysfunction. Urology. 2002;59(6):803–10.CrossRefPubMedGoogle Scholar
  6. Bartsch G, Daneshmand S, Skinner EC, Syan S, Skinner DG, Penson DF. Urinary functional outcomes in female neobladder patients. World J Urol. 2014;32(1):221–8.CrossRefPubMedGoogle Scholar
  7. Basmaijan JV. Biofeedback – principles and practice for clinicians. Baltimore/Hong Kong/London/Sydney: Wiliams and Wilkins; 1989.Google Scholar
  8. Bayerle-Eder M. Sexualität im Alter und bei chronischen Erkrankungen aufrechterhalten. Gynakol Geburtshilfe. 2015;20(Suppl 7):34–6.CrossRefGoogle Scholar
  9. Bergant A, Marth C. Sexualität nach der Therapie gynäkologischer Malignome. In: Petru E, Jonat W, Fink D, Köchli O, editors. Praxisbuch Gynäkologische Onkologie. 2nd ed. Berlin/Heidelberg: Springer; 2009.Google Scholar
  10. Bergman B, Knutson F. Renal infection after ileal conduit urinary diversion. An autopsy study. Acta Pathol Microbiol Scand A. 1978;86(3):245–50.PubMedGoogle Scholar
  11. Bosshardt RJ, Farwerk R, Sikora R, Sohn M, Jakse G. Objective measurement of the effectiveness, therapeutic success and dynamic mechanism of the vacuum device. Br J Urol. 1994;75(6):786–91.CrossRefGoogle Scholar
  12. Cabric M, Appell HJ. Effect of electrical stimulation of high and low frequency on maximum isometric force and some morphological characteristics in men. Int J Sports Med. 1987;8(4):256–60.CrossRefPubMedGoogle Scholar
  13. Calton JB. Prevalence of micronutrient deficiency in popular diet plans. J Int Soc Sports Nutr. 2010;7:24–33.CrossRefPubMedPubMedCentralGoogle Scholar
  14. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO Jr, Engstrom PF, Ezdinli PF, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rodenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tomey DC. (Eastern cooperative oncology group). Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med. 1980;69(4):491–7.CrossRefPubMedGoogle Scholar
  15. DiNubile NA. Strength training. Clin Sports Med. 1991;10(1):33–62.PubMedGoogle Scholar
  16. Hanjalic-Beck A, Farthmann J, Hasenburg A. Sexualität der Frau nach onkologischer Therapie. Forum. 2012;27(2):127–31.CrossRefGoogle Scholar
  17. Hautmann RE, Abol-Enein H, Davidsson T, Gudjonsson S, Hautmann SH, Holm HV, Lee CT, Liedberg F, Madersbacher S, Manoharan M, Mansson W, Mills RD, Penson DF, Skinner EC, Stein R, Studer UE, Thueroff JW, Turner WH, Volkmer BG, Xu A. ICUD-EAU international consultation on bladder cancer 2012: urinary diversion. Eur Urol. 2013;63(1):67–80.CrossRefPubMedGoogle Scholar
  18. Heathcote PS, Mactaggart PN, Boston RJ, James AN, Thompson LC, Nicol DL. Health-related quality of life in Australian men remaining disease-free after radical prostatectomy. Med J Aust. 1998;168(10):483–6.PubMedGoogle Scholar
  19. Herpetz U. Ödeme und Lymphdrainage. 4th ed. Stuttgart: Schattauer; 2010.Google Scholar
  20. Herrmann W. Vitamin B12. In: Thomas L, editor. Labor und Diagnose. 7th ed. Frankfurt: TH-Books Verlagsgesellschaft; 2008.Google Scholar
  21. Herwig R, Brinkmann OA, Sievert KD, Brodner G, Hertle L. Cystectomy causes immunosuppression in bladder cancer. In: Atala A, Slade D, editors. Bladder disease part a – research concept an clinical applications. Boston: Springer US; 2003.Google Scholar
  22. Heyns CF. Urinary tract infection associated with conditions causing urinary tract obstruction and stasis, excluding urolithiasis and neuropathic bladder. World J Urol. 2012;30(1):77–83.CrossRefPubMedGoogle Scholar
  23. Jemtzik F, Schrader AJ, de Petriconi R, Hefty R, Mueller J, Doetterl J, Eickhoff A, Schrader M. The neobladder in female patients with bladder cancer: long-term clinical, functional, and oncological outcome. World J Urol. 2012;30(6):733–9.CrossRefGoogle Scholar
  24. Karl A, Rittler P, Buchner A, Fradet V, Speer R, Walther S, Stief GC. Prospective assessment of malnutrition in urologic patients. Urology. 2009;73(5):1072–6.CrossRefPubMedGoogle Scholar
  25. Kim KH, Yoon HS, Yoon H, Chung WS, Sim BS, Ryu DR, Lee DH. Risc factors for developing metabolic acidosis after radical cystectomy and ileal neobladder. PLoS One. 2016;11(7):e0158220. Available from CrossRefPubMedPubMedCentralGoogle Scholar
  26. Khorrami MH, Javid A, Izadpanaki MH, Alizadeh F, Zargham M, Khorrami F. Efficacy of long-term acting octreoide on reducing mucus production in patients with ileal neobladder. Clin Genitourin Cancer. 2017;15(1):e9–e13. 2016.10012. Available from CrossRefPubMedGoogle Scholar
  27. Koch MO, McDougal WS. Nicotinic acid: treatment for the hyperchloremic acidosis following urinary diversion through intestinal segments. Chlorpromazine: adjuvant therapy for the metabolic derangements created by urinary diversion through intestinal segments. J Urol. 1985;134(1):162–9.CrossRefPubMedGoogle Scholar
  28. Kovnerystyy O, Bruch-Gerharz D, Ruzicka T, Stege H. Sekundäres Lymphödem – Eine therapeutische Herausforderung. Hautarzt. 2006;57(4):333–5.CrossRefPubMedGoogle Scholar
  29. Kurtz A. Funktion der Nieren und Regulation des Wasser- und Elektrolythaushalts. In: Löffler G, Pertrides PE, Heinrich PC, editors. Biochemie und Pathobiochemie. 8th ed. Heidelberg: Springer; 2007.Google Scholar
  30. Mathur S, Plank L, Hill AG, Rice MA, Hill GL. Change in body composition, muscle function and energy expenditure after radical cystectomy. BJU Int. 2008;101(8):973–7.CrossRefPubMedGoogle Scholar
  31. May M, Fritsche H, Gilfrich C, Brookman-May S, Burger M, Otto W, Bolenz C, Trojan E, Herrmann E, Michel MS, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Müller O, Bretschneider-Ehrenberg P, Zacharias M, Gunia S, Bastian PJ. Einfluss des Alters auf das karzinomspezifische Überleben nach radikaler Zystektomie. Urologe. 2011;50(7):821–9.CrossRefPubMedGoogle Scholar
  32. Naganuma T, Takemoto Y, Maeda S, Iwai T, Kuwabara N, Sholi T, Okamura M, Nakatani T. Chronic kidney disease in patients with ileal conduit urinary diversion. Exp Ther Med. 2012;4(6):962–6.CrossRefPubMedPubMedCentralGoogle Scholar
  33. N’Dow J, Robson CN, Metthews JN, Neal DE, Pearson JP. Reducing mucus production after urinary reconstruction: a prospective randomized trial. J Urol. 2001;165(5):1433–40.CrossRefPubMedGoogle Scholar
  34. Norman K, Pichard C, Lochs H, Pirlich M. Prognostic impact of disease-related malnutrition. Clin Nutr. 2008;27(1):5–15.CrossRefPubMedGoogle Scholar
  35. Pirlich M, Schutz T, Norman K, Gastell S, Lubke HJ, Bischoff SC. The Genman hospital malnutrition study. Clin Nutr. 2006;25(4):563–72.CrossRefPubMedGoogle Scholar
  36. Schmid L, Zellmann K, Liedl B, Clemm C, Weber B. Rehabilitation. In: Tumorzentrum München, editor. Urogenitale Tumoren – Empfehlungen zur Diagnostik, Therapie und Nachsorge. 3rd ed. München/Wien/New York: Zuckschwerdt Verlag; 2003.Google Scholar
  37. Shigemura K, Tanaka K, Matsumoto M, Nakano Y, Shirakawa T, Miyata M, Yamashita M, Arkawa S, Fujisama M. Post-operative infection and prophylactic antibiotic administration after radical cystectomy with orthotopic neobladder urinary diversion. J Infect Chemother. 2012;18(4):479–84.CrossRefPubMedGoogle Scholar
  38. Sivarajan G, Prabhu V, Taksler GB, Laze J, Lepor H. Ten-year outcomes of sexual function after radical prostatectomy: results of a prospective longitudinal study. Eur Urol. 2014;65(1):58–65.CrossRefPubMedGoogle Scholar
  39. Stadler TC, Siebels M. Therapie der erektilen Dysfunktion nach uro-onkologischen Eingriffen oder Strahlentherapie. In: Tumorzentrum München Manual, editor. Manual Urogenitale Tumoren. 4th ed. München/Wien/New York: W. Zuckschwerdt Verlag; 2008.Google Scholar
  40. Sullivan DH, Sun S, Walls RC. Protein-energy undernutrition amongm elderly hospitalized patients: a prospective study. JAMA. 1999;28(21):2013–2019.CrossRefGoogle Scholar
  41. Suriano F, Gallucci M, Flammia GP, Musco S, Alcini A, Imbalzano G, Dicuonzo G. Bacteriuria in patients with an orthotopic ileal neobladder: urinary tract infection or asymptomatic bacteriuria? BJU Int. 2008;101(12):1576–9.CrossRefPubMedGoogle Scholar
  42. Tinelli A, Mynbaev OA, Tsin DA, Giorda G, Malvasi A, Guido M, Nezhat FR. Lymphocele prevention after pelvic laparoscopic lymphadenectomy by a collagen patch coated with human coagulation factors: a matched case control study. Int J Gynecol Cancer. 2013;23(5):956–63.CrossRefPubMedGoogle Scholar
  43. Tomlinson J, Wright D. Impact of erectile dysfunction and its subsequent treatment with sildenafil: qualitative study. BMJ. 2004;328:1037. Available from Cited 2016 Dec 17CrossRefPubMedPubMedCentralGoogle Scholar
  44. Tries J. Kegel exercises enhanced by biofeedback. J Enterostomal Ther. 1990;17(2):67–76.PubMedGoogle Scholar
  45. Turk TM, Koleski FC, Albala DM. Incidence of urolithiasis in cystectomy patients after intestinal conduit or continent urinary diversion. World J Urol. 1999;17(5):305–7.CrossRefPubMedGoogle Scholar
  46. Vahlensieck W., Gäck M., Gleißner J., Liedke S., Otto U., Sauerwein D.†, Schindler E., Schultheis H., Sommmer F., Templin R., Zellner M. Struktur- und Prozeßqualität der stationären urologischen Rehabilitation Urologe A 2005; 44(1): 51–56.CrossRefPubMedGoogle Scholar
  47. Van der Aa F, Joniau S, van den Branden M, van Poppel H. Metabolic changes after urinary diversion. Adv Urol. 2011;2011:764325. Scholar
  48. Wagenlehner F, Pilatz A, Weidner W, Zwergel T, Zwergel U, Schlimmer P. Entzündung. In: Hautmann R, Gschwend JE, editors. Urologie. 5th ed. Berlin/Heidelberg: Springer; 2014.Google Scholar
  49. Weinberger V, Cibula D, Zikon M. Lymphocele: prevalence and management in gynecological malignancies. Expert Rev Anticancer Ther. 2014;14(3):307–17.CrossRefPubMedGoogle Scholar
  50. Wiedemann A, Zumbé J. Situation der Physiotherapie in der Harninkontinenzbehandlung – Ergebnisse einer bundesweiten Umfrage GIH Referateband, 11. Deutscher Kongreß der GIH, Dresden; 1999.Google Scholar
  51. World Health Organisation. International classification of functioning, disability and health. Genf; 2001.Google Scholar
  52. Zellner M, Riedl R. Rehabilitation der Erektionsfunktion nach radikaler Prostatektomie. Potenzhilfen: Bessere Aufklärung schafft mehr Akzeptanz. Uro-News. 2008;10(3):28–34.Google Scholar
  53. Zellner M, Zellmann K, Strätz M. Uro-Onkologische Rehabilitation. In: Treiber U, Zaak D, editors. Manual urogenitale tumoren. 4th ed. München/Wien/New York: W. Zuckschwerdt; 2008.Google Scholar
  54. Zellner M. Inkontinenz nach radikaler Prostatektomie und Zystektomie. Sind apparatives Kontinenztraining und Ganzkörpervibration effektiv? Urologe. 2011;50(4):433–44.CrossRefPubMedGoogle Scholar
  55. Zellner M, Ridderskamp D, Zanker F, Riedl R. Katabolie nach radikaler Zystektomie – Wirksamkeit einer hochdosierten Eiweißsubstitution. 40. Gemeinsame Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie, Erlangen, 15 May 2014.Google Scholar
  56. Zellner M. Intermittierende Vakuumtherapie zur konservativen Behandlung postoperativer Lymphozelen nach radikaler Tumorchirurgie im kleinen Becken. 41. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie und der Bayerischen Urologenvereinigung, Linz, 11 June 2015–12. June 2015.Google Scholar
  57. Zettl S, Hartlapp J. Krebs und Sexualität. Ein Ratgeber für Krebspatienten und ihre Partner. St. Augustin: Weingärtner; 2008.Google Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • Michael Zellner
    • 1
    Email author
  • David Ridderskamp
    • 1
  • Mohamed Fawzy
    • 1
  1. 1.Abteilung Urologie | Neuro-UrologieJohannesbad Fachklinik Bad FüssingBad FüssingGermany

Section editors and affiliations

  • Wolfgang Otto
    • 1
  • Shahrokh F. Shariat
    • 2
  1. 1.der Universität RegensburgOberarzt der Klinik für UrologieRegensburgGermany
  2. 2.Departement of UrologyWeill Cornell Medical CenterNew YorkUSA

Personalised recommendations